Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

Ramos finished 2024 with a 27-7 record and a Round of 12 loss to Lehigh’s Luke Stanich ... some indication of where two of top 10 athletes in the weight class stack up and what Crookham ...

Though relatively few states currently pay for GLP-1s for weight loss, all 12 programs that reported coverage as of early ...

When runners were made 10 percent lighter via a series of pulleys ... exercise, and nutrition programs for holistic weight ...

According to the American Association of Nurse Practitioners, there are more than 385,000 nurse practitioners (NPs) licensed in the United States. NPs have advanced clinical education and training, ...

NIH Study Demonstrates Long-Term Benefits of Weight-Loss Surgery in Young People - Seeing Greater Remission of Type 2 ...

Most U.S. states do not currently cover highly sought after weight-loss drugs from Novo Nordisk and Eli Lilly in their ...

We expect to select candidates for all three programs in 2025. In obesity, we are advancing WVE-007, our GalNAc-siRNA ...

CinFina Pharma, a CinRx portfolio company dedicated to advancing a portfolio of high-impact treatment options for obesity, today announced topline int ...

Viking isn't a biotech that will need to take out a lot of debt or issue a lot of new shares to get its therapies out the door. Therefore, buying its stock won't leave you at as high of a risk of your ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim their waistlines, a new report finds.